Trial Profile
A clinical trial of shared epitope peptides in rheumatoid arthritis (RA)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs DnaJP1 (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- 13 Nov 2009 Results have been published in Arthritis & Rheumatism, according to a Adeona Pharmaceuticals media release.
- 13 Nov 2009 Results of this trial have been presented at the 2008 American College of Rheumatology Annual meeting, according to a Adeona Pharmaceuticals media release.
- 28 Oct 2008 Results presented the American College of Rheumatology (ACR) annual meeting 2008, as reported in an Adeona Pharmaceuticals Media Release.